Global API Intermediates Market - Industry Trends and Forecast to 2028

Segmentation

Short Description Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028 Market Definition: Active pharmaceutical ingredients are the substance or combination of substances intended to be used in the manufacturing of a drug product which when used in the production of the drug, becomes an active pharmaceutical ingredient. Such substances are used to provide pharmacological activity. Market Segmentation: The API intermediates market is segmented on the basis of the type, product, therapeutic class, customers, end users and distribution channel. On the basis of type, the API intermediates market is segmented into veterinary drug intermediates and pharmaceutical / bulk drug intermediates On the basis of product, the API intermediates market is segmented into bromo compound, O-benzyl salbutamol, hemisulfate, oxirane, bisoprolol base, chiral PCBHP, pheniramine base, chlorpheniramine base, brompheniramine base, mepyramine/pyrilamine base, 6-amino-1,3-dimethyl uracil, theofylline, acefylline, xanthine, nitriles and others On the basis of therapeutic type, the API intermediates market is segmented into autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, urology and others On the basis of customers, the API intermediates market is segmented into direct users/pharma companies, traders/wholesalers/distributors and associations/govt. institutions/Pvt institutions On the basis of end user, the API intermediates market is segmented into API manufacturer and finished product manufacturer On the basis of distribution channel, the API intermediates market is segmented into direct tender, retail sales and others Market Players: The key market players for global API intermediates market are listed below: HIKAL Ltd. Cambrex Corporation Ganesh-Group AlzChem Group AG Vasudha Pharma Anyang General Chemical Co.,Ltd. Sarex Sandoo Pharmaceuticals and Chemicals Co., Ltd. Atul Ltd Sandoz International GmbH (a subsidiary of Novartis AG) Aceto Supriya Lifescience Ltd. LEVACHEM COMPANY LIMITED Vertellus Dishman Carbogen Amcis Ltd Sanofi Divi's Laboratories Limited AARTI INDUSTRIES LIMITED Aurobindo Pharma BASF SE

Methodology